ABC News has posted a brief story about Provenge. Most of us hope that sometime this week the FDA will finally approve Provenge. To see the brief video interview about Provenge click here. Joel T Nowak, MA, MSW
More from my explorations at the American Association of Cancer Researchers (AACR) conference in Washington, D.C. Abstract 5386 described a study using a thalidomide analogue called lenalidomide (Revlimid), in combination with Taxotere, which currently is the only approved drug for chemotherapy for advanced, metastatic castrate resistant prostate cancer. […]
Everyday set aside some time to ask yourself two important questions; 1- What am I living for? 2- What can I do or change and to make the world a better place? Joel T Nowak, MA, MSW
There were many themes running through the recent American Association of Cancer Researchers (AACR) conference that I just attended in Washington D.C. One significant theme running through the conference was the need to develop personalized medicine to be able to successfully control cancer. This leads us to the question, What is personalized medicine? [...]
No matter what happens to us, the bottom line reality is that all of our experiences in this lifetime will come to an end at some point and in some way. There is no getting around, no avoiding this simple truth. As I think about our spirituality and how we experience life, I cling to [...]